Deborah H. Telman - Jul 25, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: EVP, Corporate Affairs & GC
Signature: /s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Stock symbol: GILD
Transactions as of: Jul 25, 2023
Transactions value $: -$322,358
Form type: 4
Date filed: 7/26/2023, 04:53 PM
Previous filing: May 26, 2023
Next filing: Oct 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+8.23K	+2189.1%		8.61K	Jul 25, 2023	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$322K	-4.17K	-48.5%	$77.23	4.43K	Jul 25, 2023	Direct
transaction	GILD	Common Stock	Options Exercise		+2.06K	+46.42%		6.49K	Jul 25, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-8.23K	-19.08%		34.9K	Jul 25, 2023	Common Stock	8.23K		Direct	F1, F2
transaction	GILD	Restricted Stock Unit	Options Exercise		-2.06K	-5.9%		32.9K	Jul 25, 2023	Common Stock	2.06K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.
F3	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.